Humoral and cell-mediated response in colostrum after exposure to severe acute respiratory syndrome coronavirus 2 [preprint]
Authors
Narayanaswamy, VigneshPentecost, Brian
Alfandari, Dominique
Chin, Emily
Minor, Kathleen
Kastrinakis, Alyssa
Lieberman, Tanya
Arcaro, Kathleen F.
Leftwich, Heidi
UMass Chan Affiliations
School of MedicineDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine
Document Type
PreprintPublication Date
2021-01-04Keywords
Obstetrics and Gynecologycolostrum
immune response
infants
SARS-CoV-2
COVID-19
Immunology and Infectious Disease
Infectious Disease
Maternal and Child Health
Obstetrics and Gynecology
Virus Diseases
Metadata
Show full item recordAbstract
Background: Colostrum provides an immune sharing between a mother and her infant. The transfer in colostrum of antibodies against SARS-CoV-2 and the elicited cytokines may provide crucial protection to the infant. There is limited literature on the immune response to SARS-CoV-2 present in colostrum. Objective: To evaluate the presence of antibodies specific to SARS-CoV-2 and the associated cytokines in colostrum from women who tested positive for the virus. Study Design: Between March and September 2020 we obtained bilateral colostrum samples collected on spot cards within 48 hours of delivery from 15 new mothers who had previously tested positive for SARS-CoV-2. Five of these 15 COVID-19 positive women also provided bilateral liquid colostrum within 1-2 days of providing the spot card samples. Archived bilateral colostrum samples collected from 8 women during 2011-2013 were used as pre-COVID-19 controls. All samples were tested for reactivity to the Receptor Binding Domain (RBD) of the SARS-CoV-2 spike protein using an ELISA that measures SARS-CoV-2 RBD-specific IgA, IgG, and IgM, and for concentrations of 10 inflammatory cytokines (IFNγ, TNFα, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13) using a multiplex electrochemiluminescent sandwich assay. Results: Bilateral colostrum samples from 73%, 73% and 33% of the 15 COVID-19 mothers exhibited IgA, IgG, and IgM reactivity to RBD respectively. Colostrum samples from two of the 8 pre-pandemic controls showed IgA and IgG reactivity to RBD. Additionally, COVID-19 mothers had significantly higher levels of 9 of the 10 inflammatory markers (all except IFNγ) as compared to the pre-COVID-19 controls. Comparable results were obtained with both the spot card-eluates and liquid samples. Conclusions: A strong humoral immune response is present in the colostrum of women who were infected with SARS-CoV-2 before delivering. High levels of 9 inflammatory markers were also present in the colostrum. The evolution and duration of the antibody response, as well as dynamics of the cytokine response, remain to be determined. Our results also indicate that future large-scale studies can be conducted with milk easily collected on paper spot cards.Source
medRxiv 2021.01.03.20248715; doi: https://doi.org/10.1101/2021.01.03.20248715. Link to preprint on medRxiv.
DOI
10.1101/2021.01.03.20248715Permanent Link to this Item
http://hdl.handle.net/20.500.14038/29661Notes
This article is a preprint. Preprints are preliminary reports of work that have not been certified by peer review.
Rights
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.Distribution License
http://creativecommons.org/licenses/by-nd/4.0/ae974a485f413a2113503eed53cd6c53
10.1101/2021.01.03.20248715
Scopus Count
Except where otherwise noted, this item's license is described as The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.